Literature DB >> 18830725

Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain.

I Suárez-García1, A Rodríguez-Blanco, J L Vidal-Pérez, M A García-Viejo, M J Jaras-Hernández, O López, A Noguerado-Asensio.   

Abstract

The setting for this retrospective cohort study was a specialised tuberculosis unit in Madrid, Spain. The objective was to describe the risk factors for multidrug-resistant tuberculosis (MDR-TB). The medical records of all patients admitted to the unit were reviewed retrospectively to identify factors associated with multidrug resistance. Patients with positive culture for M. tuberculosis and with available drug-susceptibility tests were included. The variables assessed were age, gender, country of origin, homelessness, alcohol consumption, intravenous drug use, methadone substitution therapy, contact with a tuberculosis patient, sputum smear, site of disease, previous tuberculosis treatment, HIV infection, history of imprisonment, diabetes mellitus and chronic obstructive pulmonary disease. Thirty patients with MDR-TB and 666 patients with non-MDR-TB were included from the years 1997 to 2006. The only factors associated with MDR-TB in multivariate analysis were previous tuberculosis treatment (OR: 3.44; 95% CI: 1.58-7.50; p = 0.003), age group 45-64 years (OR: 3.24; 95% CI: 1.34-7.81; p = 0.009) and alcohol abuse (OR: 0.12; 95% CI: 0.03 to 0.55; p = 0.003). In our study, patients who had had previous treatment for tuberculosis, who were 45-64 years of age or who had no history of alcohol abuse were more likely to have MDR-TB.

Entities:  

Mesh:

Year:  2008        PMID: 18830725     DOI: 10.1007/s10096-008-0627-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

Review 1.  [Drug-resistant tuberculosis in Spain. Trends and influence of the human immunodeficiency virus].

Authors:  P de March Ayuela
Journal:  Med Clin (Barc)       Date:  2001-06-16       Impact factor: 1.725

2.  [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].

Authors:  G CANETTI; N RIST; J GROSSET
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1963 Feb-Mar

3.  A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis.

Authors:  F A Drobniewski; S A Watterson; S M Wilson; G S Harris
Journal:  J Med Microbiol       Date:  2000-03       Impact factor: 2.472

4.  Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

Authors:  K F Laserson; L E Thorpe; V Leimane; K Weyer; C D Mitnick; V Riekstina; E Zarovska; M L Rich; H S F Fraser; E Alarcón; J P Cegielski; M Grzemska; R Gupta; M Espinal
Journal:  Int J Tuberc Lung Dis       Date:  2005-06       Impact factor: 2.373

5.  Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain)

Authors:  M Arévalo; J Solera; D Cebrian; J Bartolomé; P Robles
Journal:  Eur Respir J       Date:  1996-02       Impact factor: 16.671

6.  Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999.

Authors:  T Djuretic; J Herbert; F Drobniewski; M Yates; E G Smith; J G Magee; R Williams; P Flanagan; B Watt; A Rayner; M Crowe; M V Chadwick; A M Middleton; J M Watson
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

7.  [Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis].

Authors:  N Martin-Casabona; F Alcaide; P Coll; J González; J M Manterola; M Salvadó; J A Caylà
Journal:  Med Clin (Barc)       Date:  2000-10-21       Impact factor: 1.725

8.  Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation.

Authors:  P Spradling; E Nemtsova; T Aptekar; M Shulgina; L Rybka; C Wells; G Aquino; H Kluge; W Jakubowiak; N Binkin; B Kazeonny
Journal:  Int J Tuberc Lung Dis       Date:  2002-09       Impact factor: 2.373

9.  Determinants of drug-resistant tuberculosis: analysis of 11 countries.

Authors:  M A Espinal; K Laserson; M Camacho; Z Fusheng; S J Kim; R E Tlali; I Smith; P Suarez; M L Antunes; A G George; N Martin-Casabona; P Simelane; K Weyer; N Binkin; M C Raviglione
Journal:  Int J Tuberc Lung Dis       Date:  2001-10       Impact factor: 2.373

10.  Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India.

Authors:  K Jaggarajamma; G Sudha; V Chandrasekaran; C Nirupa; A Thomas; T Santha; M Muniyandi; P R Narayanan
Journal:  Indian J Tuberc       Date:  2007-07
View more
  29 in total

Review 1.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

2.  Degradation of myxovirus virion RNA by periodate.

Authors:  G A Tannock; I P Griffith
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

3.  Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation.

Authors:  A C Miller; I Y Gelmanova; S Keshavjee; S Atwood; G Yanova; S Mishustin; J J Furin; S S Shin
Journal:  Int J Tuberc Lung Dis       Date:  2012-04-09       Impact factor: 2.373

4.  Global Impact of Multidrug-Resistant Pulmonary Tuberculosis Among HIV-Infected and Other Immunocompromised Hosts: Epidemiology, Diagnosis, and Strategies for Management.

Authors:  Charles D Wells
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

5.  Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran.

Authors:  Aliasghar Farazi; Masoomeh Sofian; Nader Zarrinfar; Fatemeh Katebi; Seyed Davood Hoseini; Roohollah Keshavarz
Journal:  Caspian J Intern Med       Date:  2013

6.  Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana.

Authors:  N M Zetola; C Modongo; E C Kip; R Gross; G P Bisson; R G Collman
Journal:  Int J Tuberc Lung Dis       Date:  2012-09-07       Impact factor: 2.373

7.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

8.  Epidemiology of anti-tuberculosis drug resistance in a Chinese population: current situation and challenges ahead.

Authors:  Yan Shao; Dandan Yang; Weiguo Xu; Wei Lu; Honghuan Song; Yaoyao Dai; Hongbing Shen; Jianming Wang
Journal:  BMC Public Health       Date:  2011-02-17       Impact factor: 3.295

Review 9.  Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care.

Authors:  Fantahun Biadglegne; Ulrich Sack; Arne C Rodloff
Journal:  Antimicrob Resist Infect Control       Date:  2014-10-03       Impact factor: 4.887

10.  Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study.

Authors:  Getahun Yeshiwas Ambaye; Gebiyaw Wudie Tsegaye
Journal:  Ethiop J Health Sci       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.